AANA Journal: A Retrospective Study: Multimodal Analgesia Quality Measure Implementation and Patient Outcome Assessment

Availability

On-Demand

Expires on Mar 18, 2027

Cost

$0.00

Credit Offered

2 Class A Credits

1 Pharmacology Credit

The current literature does not examine whether administering two or more MAs included in MIPS 477 improves the quality measures previously identified. Therefore, our study aims to address this question on whether or not there are any benefits to the quality measures. The opioid epidemic is a major public health concern in the United States. To address this, the Centers for Medicare & Medicaid Services recommends the use of two or more nonopioid multimodal analgesics (MAs) during the perioperative period from 6 hours prior to anesthesia start time until discharge from the postanesthesia care unit (PACU). This recommendation is accounted for by the Merit-based Incentive Payment System (MIPS) 477, a financial incentive program that adjusts reimbursement based on the anesthesia provider’s quality performances.3 This program was implemented by the anesthesia providers at a Level 2 trauma hospital in the Mid-Atlantic region for surgical patients in the perioperative setting. However, there was no data analysis on the following quality measures: perioperative opioid consumption, postoperative nausea and vomiting (PONV), and pain scores. Furthermore, it was unknown if the protocol implementation resulted in beneficial clinical outcomes.

Learning Outcomes:

Summarize the effects of two or more multimodal analgesia on patients’ perioperative opioid consumption.

Summarize the effects of two or more multimodal analgesia on patients’ postoperative nausea and vomiting (PONV).

Summarize the effects of two or more multimodal analgesia on patients’ pain scores.

Noah Lee, DNAP, CRNA

Jamie Feldt, DNAP, CRNA

Carrie Bowman, PhD, CRNA

Brent Lee, MD, MPH, FASA

Nicole Grass, DNP, CRNA

Nancy Crowell, PhD

Ladan Eshkevari, PhD, CRNA, LAc, FAAN

Accreditation Information:
The American Association of Nurse Anesthesiology is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

AANA is an approved provider by the California Board of Registered Nursing, CEP #10862.

Disclosure Statement:
Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Post-Test Attempt Notice:
A minimum passing score of 80% is required to pass this course. You have TWO opportunities to achieve a passing score. If you fail to achieve a passing score of 80%, you will not receive CE credit for this course.

Content Disclaimer:
The views, information, or opinions expressed within the videos and audio are solely those of the individuals involved and do not necessarily represent those of the American Association of Nurse Anesthesiology.

Course content has been prepared by the presenter/developer, and each viewer agrees that the presenter/developer is solely responsible for the content and the accuracy thereof. The viewer agrees that the American Association of Nurse Anesthesiology has no responsibility or liability for the accuracy or completeness of the content.

Refund Policy:
Continuing education activities are nonrefundable.